Vaccinia virus A35R inhibits MHC class II antigen presentation

被引:30
|
作者
Rehm, Kristina E. [1 ]
Connor, Ramsey F. [1 ]
Jones, Gwendolyn J. B. [1 ]
Yimbu, Kenneth [1 ]
Roper, Rachel L. [1 ]
机构
[1] E Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC 27834 USA
关键词
Poxvirus; Vaccinia; Macrophage; Antigen presentation; Cytokine; Apoptosis; MHC; HUMAN DENDRITIC CELLS; SMALLPOX VACCINATION; NITRIC-OXIDE; T-CELLS; INFECTION; POXVIRUS; PROTEIN; VIRULENCE; EXPRESSION; MATURATION;
D O I
10.1016/j.virol.2009.11.008
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The Vaccinia virus gene A35R (Copenhagen designation) is highly conserved in mammalian-tropic poxviruses and is an important virulence factor, but its function was unknown. We show herein that A35 does not affect viral infectivity, apoptosis induction, or replication; however, we found that A35 significantly inhibited MHC class II-restricted antigen presentation, immune priming of T lymphocytes, and subsequent chemokine and cytokine synthesis. A35 localized to endosomes and reduced the amount of a model antigenic peptide displayed in the cleft of class II MHC. In addition, A35 decreased VV specific T cell responses in vivo. Thus, this is the first report identifying a function for the A35 protein in virulence as well as the first report identifying a VV gene that inhibits peptide antigen presentation. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:176 / 186
页数:11
相关论文
共 50 条
  • [1] Vaccinia virus infection induces dendritic cell maturation but inhibits antigen presentation by MHC class II
    Yao, Yongxue
    Li, Ping
    Singh, Pratibha
    Thiele, Allison T.
    Wilkes, David S.
    Renukaradhya, Gourapura J.
    Brutkiewicz, Randy R.
    Travers, Jeffrey B.
    Luker, Gary D.
    Hong, Soon-Cheol
    Blum, Janice S.
    Chang, Cheong-Hee
    [J]. CELLULAR IMMUNOLOGY, 2007, 246 (02) : 92 - 102
  • [2] Disruption of the MHC class II restricted antigen presentation pathway by vaccinia virus
    Li, P
    Brutkiewicz, RR
    Blum, JS
    [J]. FASEB JOURNAL, 2003, 17 (07): : C307 - C307
  • [3] Disruption of MHC class II-restricted antigen presentation by vaccinia virus
    Li, P
    Wang, N
    Zhou, DL
    Yee, CSK
    Chang, CH
    Brutkiewicz, RR
    Blum, JS
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 175 (10): : 6481 - 6488
  • [4] The vaccinia virus A35R protein inhibits antigen presentation and suppresses cytokine synthesis by responding CD4+T cells
    Rehm, Kristina Elizabeth
    Connor, Ramsey
    Jones, Gwendolyn
    Mannie, Mark
    Roper, Rachel L.
    [J]. FASEB JOURNAL, 2008, 22
  • [5] Characterization of the vaccinia virus A35R protein and its role in virulence
    Roper, RL
    [J]. JOURNAL OF VIROLOGY, 2006, 80 (01) : 306 - 313
  • [6] Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II
    Rehm, Kristina E.
    Connor, Ramsey F.
    Jones, Gwendolyn J. B.
    Yimbu, Kenneth
    Mannie, Mark D.
    Roper, Rachel L.
    [J]. IMMUNOLOGY, 2009, 128 (03) : 381 - 392
  • [7] Poxvirus A35 protein regulation of MHC class II antigen presentation
    Jones, Gwendolyn
    Boles, Corey
    Roper, Rachel
    [J]. MOLECULAR IMMUNOLOGY, 2015, 68 (02) : 165 - 165
  • [8] The Role of li p35 in MHC Class II Antigen Presentation
    Sand, Kine M. Knudsen
    Bakke, Oddmund
    Gregers, Tone F.
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2011, 73 (04) : 358 - 358
  • [9] Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway
    Pan, JP
    Ju, DW
    Wang, QQ
    Zhang, MH
    Xia, DJ
    Zhang, LH
    Yu, H
    Cao, XT
    [J]. IMMUNOLOGY LETTERS, 2001, 76 (03) : 153 - 161
  • [10] Antigen presentation by MHC class II molecules
    Weenink, SM
    Gautam, AM
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 1997, 75 (01): : 69 - 81